Enzyme immunoassay for the qualitative determination of specific antibodies to Durvalumab (Imfinzi®) in serum and plasma.
This kit has been especially developed for the qualitative determination of specific antibodies to Durvalumab in serum and plasma samples.
The Matriks Biotek Antibody to Durvalumab ELISA Kit can be efficiently used for monitoring anti-Durvalumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Durvalumabantibodies. Measurement of biological drug trough levels and antibody to biological drug gained high importance during the course of treatment. These measurements enable dose adjustments and switch to another class of biological drug when necessary.
All SHIKARI® ELISA kits are suitable for biosimilar work.
| Required Volume (µl) | 20 |
| Total Time (min) | 140 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | + / – |
| Spike Recovery (%) | – |
| Shelf Life (year) | 1 |
| Assay type | Qualitative |
| Species Reactivity | Human |
| Storage conditions | Store at +4°C. Please refer to protocols. |
| Shipping conditions | At room temperature |
Reviews
There are no reviews yet.